| Index | Ligand Name | Structure | PDB code | ligand desolvation |
| 1 | 2oq | Back pocket flexibility provides group-II PAK selectivity for type 1 kinase inhibitors | 4o0x | 91.64 |
| 2 | 2oo | Back pocket flexibility provides group-II PAK selectivity for type 1 kinase inhibitors | 4o0y | 89.95 |
| 3 | 9eo | Crystal Structure of PAK4 in complex with inhibitor CZg353 | 5zjw | 89.65 |
| 4 | 2ol | Back pocket flexibility provides group-II PAK selectivity for type 1 kinase inhibitors | 4o0v | 86.43 |
| 5 | 8fx | Crystal Structure of PAK4 in complex with inhibitor CZH226 | 5xvg | 85.45 |
| 6 | 8fu | Crystal Structure of PAK4 in complex with inhibitor CZH216 | 5xva | 85 |
| 7 | 7kc | Crystal Structure of the Human p21-Activated Kinase 4 in Complex with PF-03758309 | 2x4z | 82.97 |
| 8 | 4t6 | Crystal structure of P21-activated kinase 4 in complex with an inhibitor compound 29 | 5bms | 78.52 |
| 9 | 8fr | Crystal Structure of PAK4 in complex with inhibitor CZH062 | 5xvf | 76.49 |
| 10 | 23d | CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 4 IN COMPLEX WITH CGP74514A | 2cdz | 75.92 |
| 11 | n53 | Crystal Structure of the Human p21-Activated Kinase 4 in Complex with (S)-N-(5-(3-benzyl-1-methylpiperazine-4-carbonyl)-6,6-dimethyl-1,4,5, 6-tetrahydropyrrolo(3,4-c)pyrazol-3-yl)-3-phenoxybenzamide | 4app | 75.19 |
| 12 | 981 | PAK4 kinase domain in complex with FRAX486 | 5vee | 74.7 |